Anna I. Guerdjikova, PhD, LISW
- 6Articles
- 29.9KReads
- 2006–2020Active
- 25Collaborators
- 81Citations
About
Anna I. Guerdjikova, PhD, LISW, has authored multiple articles published between 2006 and 2020 focusing on clinical research related to eating disorders, weight management, and bipolar disorder. Her work includes studies on pharmacological treatments such as dasotraline, phentermine/topiramate extended release, naltrexone/bupropion, divalproex extended release, and zonisamide in the context of binge-eating disorder, obesity, major depressive disorder, and bipolar spectrum disorders. She has collaborated frequently with co-authors including Susan L. McElroy and James I. Hudson.
Publications
Naltrexone/Bupropion Combination Therapy in Overweight or Obese Patients With Major Depressive Disorder: Results of a Pilot Study
June 20, 2013
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
